{"id":453368,"date":"2019-12-03T12:14:01","date_gmt":"2019-12-03T12:14:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=453368"},"modified":"2019-12-03T12:14:01","modified_gmt":"2019-12-03T12:14:01","slug":"global-biopsy-device-market-is-anticipated-to-surpass-usd-28-billion-by-the-year-end-of-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-biopsy-device-market-is-anticipated-to-surpass-usd-28-billion-by-the-year-end-of-2025_453368.html","title":{"rendered":"Global biopsy device market is anticipated to surpass USD 2.8 Billion by the year end of 2025"},"content":{"rendered":"
\"Global<\/a><\/p>\n
\n
Global biopsy device market is anticipated to USD 2.8 Billion by 2025.<\/div>\n<\/div>\n<\/div>\n
Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy and Others) Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.).<\/div>\n

Renub Research<\/strong> report titled “Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application, Companies”<\/strong> captures a detailed analysis of global Biopsy Devices market and volume and provides an all-encompassing analysis of the key growth drivers and preventive factors, key players and their projections for the future. Global Biopsy Device Market<\/a> is anticipated to surpass USD 2.8 Billion<\/strong> by the year end of 2025<\/strong>.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

Biopsy refers to surgical removal of a tissue from any human organ in order to know the existence of a particular cancer disorder. This procedure is performed by surgeons, cardiologists and radiologists. The use of each biopsy tool can vary depending on the type of organ being considered.<\/p>\n

The main factor driving market growth is minimal invasive surgery which mitigates risks and side effects. In addition, increasing awareness about chronic disease diagnosis increases demand for advanced biopsy technologies such as stereotactic-guided biopsy. Nevertheless, high biopsy procedure costs and limited availability of skilled professionals in low-income countries are hampering market growth.<\/p>\n

 <\/p>\n

Request a free sample copy of the report:<\/strong> https:\/\/www.renub.com\/request-sample-page.php?gturl=defibrillator-market-forecast-p.php<\/a><\/p>\n

 <\/p>\n

Biopsy was one of the main cancer disease screening methods and is commonly used in breast, hair, and prostate cancer diagnosis. According to the World Cancer Report, cancer rates will continue to rise to 15 million new cases by 2020. Therefore, the market is expected to increase with the rising incidence of cancer cases and advancements in biopsy devices.<\/p>\n

Most countries have services for early breast cancer detection. These policies will therefore increase the rate of adoption of biopsy devices and thus have a positive impact on the development of the industry of biopsy devices in the foreseeable future.<\/p>\n

Market Summary:<\/strong><\/p>\n

By Segments:<\/strong> The product-based demand for biopsy devices is categorized into Biopsy Needles, Guidance Systems, Biopsy Guns, Reagents and kits and others. The needle-based biopsy tools gained the largest market share of biopsy products in 2018. This segment is also expected to grow at the fastest rate in the forecast period due to an increase in breast cancer, gastrointestinal tract diseases and soft tissue sarcomas.<\/p>\n

By Application:<\/strong> Breast biopsy in the product segment which has produced the highest revenue in 2018 and is expected to maintain its dominance over the forecast period, according to the report. This is due to an increase in the number of patients with breast cancer who have been observed across the globe over the years and are expected to continue this trend in the future.<\/p>\n

By Regions:<\/strong> Due to the high availability of trained medical professionals, the existence of well-developed infrastructure facilities and the presence of a number of key players, North America holds the largest market share in 2018 and is expected to maintain its dominance during the forecast period.<\/p>\n

 <\/p>\n

Request a free Brochure copy of the report:<\/strong> https:\/\/www.renub.com\/request-brochure-page.php?gturl=biopsy-devices-market-global-forecast-p.php<\/a><\/p>\n

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.<\/strong><\/p>\n

 <\/p>\n

Browse Related Reports :<\/strong><\/p>\n

Insulin Pump Market<\/a><\/p>\n

Blood Glucose Device Market<\/a><\/p>\n

 <\/p>\n

Contact Us<\/strong>
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com<\/p>\n

Key Topics Covered :<\/strong><\/p>\n

1.    Introduction<\/strong><\/p>\n

2.    Research Methodology<\/strong><\/p>\n

3.    Executive Summery<\/strong><\/p>\n

4.    Global – Biopsy Devices Market<\/strong><\/p>\n

5.    Market Share – Global Biopsy Devices<\/strong><\/p>\n

      5.1    By Product
      5.2    By Application
      5.3    By Region
      5.4    By End-User<\/p>\n

6.    By Product – Biopsy Devices Market<\/strong><\/p>\n

      6.1    Biopsy Needles
      6.2    Guidance Systems
      6.3    Biopsy Guns
      6.4    Reagents and kits
      6.5    Others (Brushes, Curettes and Punches etc)<\/p>\n

7.    By Application – Biopsy Devices Market<\/strong><\/p>\n

      7.1    Breast Biopsy
      7.2    Lung Biopsy
      7.3    Prostate Biopsy
      7.4    Others<\/p>\n

8.    By Region – Biopsy Devices Market<\/strong><\/p>\n

      8.1    North America
      8.2    Europe
      8.3    Asia-Pacific
      8.4    Rest of World<\/p>\n

9.    By End – User – Biopsy Devices Market<\/strong><\/p>\n

      9.1    Diagnostic Center
      9.2    Hospitals
      9.3    Others
      9.4    C. R. Bard, Inc. – Company Analysis
      9.5    Overview
      9.6    Merger & Acquisition
      9.7    Financial Insight<\/p>\n

10.    Becton, Dickinson and Company – Company Analysis<\/strong><\/p>\n

      10.1    Overview
      10.2    Key Devlopments
      10.3    Merger & Acquisition
      10.4    Financial Insight<\/p>\n

11.    B. Braun Melsungen AG – Company Analysis<\/strong><\/p>\n

      11.1    Overview
      11.2    Key Devlopments
      11.3    Merger & Acquisition
      11.4    Financial Insight<\/p>\n

12.    Cardinal Health, Inc. – Company Analysis<\/strong><\/p>\n

      12.1    Overview
      12.2    Key Devlopments
      12.3    Merger & Acquisition
      12.4    Financial Insight<\/p>\n

13.    Olympus Corporation – Company Analysis<\/strong><\/p>\n

      13.1    Overview
      13.2    Key Devlopments
      13.3    Merger & Acquisition
      13.4    Financial Insight<\/p>\n

14.    Boston Scientific Corporation – Company Analysis<\/strong><\/p>\n

      14.1    Overview
      14.2    Key Developments
      14.3    Merger & Acquisition
      14.4    Financial Insight<\/p>\n

15.    Medtronic plc – Company Analysis<\/strong><\/p>\n

      15.1    Overview
      15.2    Key Devlopments
      15.3    Merger & Acquisition
      15.4    Financial Insight<\/p>\n

16.    Hologic, Inc. – Company Analysis<\/strong><\/p>\n

      16.1    Overview
      16.2    Key Developments
      16.3    Merger & Acquisition
      16.4    Financial Insight<\/p>\n

17.    Growth Drivers<\/strong><\/p>\n

      17.1    Inadequate Screening Tests for Particular Cancers
      17.2    Demand for Minimally-Invasive Biopsy Technique
      17.3    Advancement in Biopsy Techniques<\/p>\n

18.    Challenges<\/strong><\/p>\n

      18.1    Breast Biopsy Reimbursement Bundling
      18.2    Biopsy Limitations<\/p>\n

 <\/p>\n

About Us:<\/strong><\/p>\n

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Renub Research<\/a>
Contact Person:<\/strong> Rajat Gupta
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 16783020700
Address:<\/strong>225 Kristie Ln
City:<\/strong> Roswell
State:<\/strong> GA
Country:<\/strong> United States
Website:<\/strong> www.renub.com\/life-science-1-c.php<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Global biopsy device market is anticipated to USD 2.8 Billion by 2025. Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,410,406,411,416],"tags":[],"class_list":["post-453368","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Manufacturing-Industry","category-Pharmaceuticals-Biotech","category-Technology","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/453368","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=453368"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/453368\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=453368"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=453368"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=453368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}